Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 3/20 | 0.68 |
| ▸ | PPARD | Q03181 | 3/20 | 0.68 |
| ▸ | PPARA | Q07869 | 3/20 | 0.68 |
| ▸ | FAAH | O00519 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | F7 | P08709 | 2/20 | 0.68 |
| ▸ | F3 | P13726 | 2/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28996487 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL6906190 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL6225308 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL28122004 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL16055762 | 0.94 | ALDH1A1 (0.71) | PPARGPPARDPPARAMAPTBLM | |
| SCHEMBL6912045 | 0.87 | CES2 (0.62) | PTPN1PPARGPPARDPPARAHSD17B10 | |
| SCHEMBL963716 | 0.87 | CES2 (0.62) | PTPN1PPARGPPARDPPARAHSD17B10 | |
| SCHEMBL6113345 | 0.87 | — | — | |
| SCHEMBL3888466 | 0.87 | CES2 (0.62) | PTPN1PPARGPPARDPPARAHSD17B10 | |
| SCHEMBL3624489 | 0.87 | CES2 (0.62) | PTPN1PPARGPPARDPPARAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112174978-B | A garcinolic acid nanometer preparation based on hydrophobic prodrug for improving long circulation | 中国药科大学 | 2022-05-20 | — | — | CN | claimed |
| CN-112174978-A | Gambogic acid nanometer preparation based on hydrophobic prodrug and capable of improving long circulation | 中国药科大学 | 2021-01-05 | — | — | CN | claimed |
| US-8987531-B2 | Syntheses of Z-olefin-containing lepidopteran insect pheromones | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-03-24 | — | — | US | claimed |
| EP-2838359-A1 | SYNTHESES OF Z-OLEFIN-CONTAINING LEPIDOPTERAN INSECT PHEROMONES | California Institute of Technology (US) | 2015-02-25 | — | — | EP | claimed |
| WO-2013134192-A1 | SYNTHESES OF Z-OLEFIN-CONTAINING LEPIDOPTERAN INSECT PHEROMONES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2013-09-12 | — | — | WO | claimed |
| US-20130231499-A1 | SYNTHESIS OF Z-OLEFIN-CONTAINING LEPIDOPTERAN INSECT PHEROMONES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2013-09-05 | — | — | US | claimed |
| US-6268534-B1 | CONTACTING OLEYL BROMIDE WITH OLEYLAMINE UNDER CONDITIONS SUITABLE FOR THE FORMATION OF N,N-DIOLEYLAMINE; METHYLATION OF N,N-DIOLEYLAMINE UNDER CONDITIONS SUITABLE FOR FORMATION OF N,N-DIOLEYL-N,N-DIMETHYLAMMONIUM CHLORIDE | RIBOZYME PHARMACEUTICALS, INC. | 2001-07-31 | — | — | US | claimed |
| US-4301083-A | BY REACTION WITH AN ORGANIC CHLORIDE OR BROMIDE IN THE PRESENCE OF SODIUM OR POTASSIUM HYDROXIDE | KURARAY CO., LTD. (JP) | 1981-11-17 | — | — | US | claimed |
| EP-4495237-B1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | ARBUTUS BIOPHARMA CORP (CA) | 2026-05-13 | — | — | EP | disclosed |
| US-12594292-B2 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4678626-A1 | LONG-CHAIN ALKENYLOXY-SUBSTITUTED BENZOYL DERIVATIVE AND OLIGONUCLEOTIDE SYNTHESIS METHOD USING SAME | Spera Pharma, Inc. (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-12453776-B2 | Lipids and compositions for the delivery of therapeutics | ARBUTUS BIOPHARMA CORPORATION (CA) | 2025-10-28 | — | — | US | disclosed |
| US-12415954-B2 | Method of producing core/shell semiconductor nanoparticles | SHOEI CHEMICAL INC. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250177428-A1 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-06-05 | — | — | US | disclosed |
| US-4036951-A | SUNSCREEN AGENTS | SYNERGISTICS, INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4028422-A | SEX ATTRACTANTS FOR FLIES | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-06-07 | — | — | US | disclosed |
| US-3971757-A | STABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1976-07-27 | — | — | US | disclosed |
| US-3969298-A | Selected lipophilic aminimides and polymers derived therefrom useful for making stable emulsions | THE KENDALL COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3966711-A | 4-Alkyl-1,4-diaza-5-oxo-cycloheptanes and their 1-oxyls | CIBA-GEIGY CORPORATION (US) | 1976-06-29 | — | — | US | disclosed |
| US-3948803-A | Catalyst | ZOECON CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12453776-B2 | Lipids and compositions for the delivery of therapeutics | PHOSPHO1, MBOAT1, SGMS1 | TERT 1523/4885PTPN1 2355/4885PPARG 560/4885 |
| US-12594292-B2 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | ACE2, SARS1, FURIN | TERT 516/4885PTPN1 3383/4885PPARG 1278/4885 |
| US-20130231499-A1 | SYNTHESIS OF Z-OLEFIN-CONTAINING LEPIDOPTERAN INSECT PHEROMONES | ZYX, OSBP, ZDHHC7 | TERT 2840/4885PTPN1 4706/4885PPARG 3716/4885 |
| US-20250177428-A1 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS | SARS1, ACE2, FURIN | TERT 851/4885PTPN1 4634/4885PPARG 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.